Encycla logo
Add page Explore

Log in Sign up

philipn
/ Dosing ARBs for COVID-19 158c42a2b5a1d36962501c3dbe4da1d7f4243ea9

Create Draft
  • Contributors
  • Drafts
  • Suggestions
  • Pages
  • Git Clone
Starting
philipn authored on Nov. 5, 2020, 9:34 p.m.

Listing current trial dosage / medication

Review changes View this version of the page
You can also use the and keys
Deletions are marked like this Additions are marked like this

If ARBs (or other drugs modulating the renin-angiotensin system) help in COVID-19, what would be the ideal dosing and medication to use?  This page explores this question.

Dose & medication used in clinical trials

  • Losartan:
    • 12.5mg bid. 200 participants total.
    • 25mg od for 14 days. Multi-arm trial, estimate ~1000 participants total.
    • 25mg od for 10 days. 580 participants total.
    • 25mg bid. 20 participants total.
    • 25mg bid for 14 days. 100 participants total.
    • 25 od, escaled to 50mg. 34 participants total.
    • 50mg od. 200 participants total.
    • 50mg od for 15 days. 176 participants total.
    • 100mg od. Multi-arm trial, estimate ~5000 participants.
    • Titration up to 100mg od over 3 days. 1372 participants total.
  • Valsartan:
    • Titrated based on BP, max 160mg bid. 651 participants total.
  • Telmisartan:
    • 20mg od. 338 participants total.
    • 40mg od for 21 days. 40 participants total.
    • 40mg od for 14 days. 60 participants total.
    • 80mg bid. 400 participants total.
  • Candesartan:
    • 4mg od, "titrated to normotension". Multi-arm trial, estimated ~50 participants total.
  • Unspecified ARB/dose:
    • CLARITY trial. 605 participants total.
Create Draft
Contributed by
Except where otherwise noted, text content is licensed under a Creative Commons Attribution-ShareAlike License. See copyright information.
  git clone https://encycla.com/@philipn/Dosing_ARBs_for_COVID-19

Git Clone

To clone this page using Git:

git clone https://encycla.com/@philipn/Dosing_ARBs_for_COVID-19